Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis

被引：11
作者：
Arita, Yoh [1 ]
Nakaoka, Yoshikazu [1 ,5 ]
Otsuki, Michio [2 ]
Higuchi, Kaori [1 ]
Hashimoto-Kataoka, Takahiro [1 ]
Yasui, Taku [1 ]
Masaki, Takeshi [1 ]
Ohtani, Tomohito [1 ]
Kishimoto, Tadamitsu [3 ]
Yamauchi-Takihara, Keiko [1 ]
Komuro, Issei [4 ]
Sakata, Yasushi [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan
[4] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1130033, Japan
[5] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 187卷
关键词：
Takayasu arteritis (TAK); Interleukin-6; Tocilizumab; Cytokine storm; Recurrence; THERAPY;
D O I：
10.1016/j.ijcard.2015.03.399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：319 / 321
页数：3
相关论文
共 50 条
  • [1] Successful Tocilizumab Treatment in a Child With Refractory Takayasu Arteritis
    Bravo Mancheno, Beatriz
    Perin, Francesca
    Rodriguez Vazquez del Rey, Maria del Mar
    Garcia Sanchez, Antonio
    Alcazar Romero, Pedro Pablo
    PEDIATRICS, 2012, 130 (06) : E1720 - E1724
  • [2] Tocilizumab for the Treatment of Patients With Refractory Takayasu Arteritis
    Nakaoka, Yoshikazu
    Higuchi, Kaori
    Arita, Yoh
    Otsuki, Michio
    Yamamoto, Kaori
    Hashimoto-Kataka, Takahiro
    Yasui, Taku
    Ikeoka, Kuniyasu
    Ohtani, Tomohito
    Sakata, Yasushi
    Shima, Yoshihito
    Kumanogoh, Atsushi
    Yamauchi-Takihara, Keiko
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    Komuro, Issei
    INTERNATIONAL HEART JOURNAL, 2013, 54 (06) : 405 - 411
  • [3] Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
    Li, Haiyan
    Shuai, Zongwen
    HEART AND VESSELS, 2022, 37 (05) : 884 - 894
  • [4] Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis Two case reports
    Asano, Tomoyuki
    Sato, Shuzo
    Temmoku, Jumpei
    Fujita, Yuya
    Furuya, Makiko Yashiro
    Matsuoka, Naoki
    Kobayashi, Hiroko
    Suzuki, Eiji
    Watanabe, Hiroshi
    Migita, Kiyoshi
    MEDICINE, 2020, 99 (04)
  • [5] Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
    Haiyan Li
    Zongwen Shuai
    Heart and Vessels, 2022, 37 : 884 - 894
  • [6] Tocilizumab in refractory Takayasu arteritis: A case series and updated literature review
    Abisror, Noemie
    Mekinian, Arsene
    Lavigne, Christian
    Vandenhende, Marie-Anne
    Soussan, Michael
    Fain, Olivier
    AUTOIMMUNITY REVIEWS, 2013, 12 (12) : 1143 - 1149
  • [7] Serum IL-6 level trajectory for predicting the effectiveness and safety of tocilizumab in the treatment of refractory Takayasu arteritis
    Sun, Xiaochuan
    Fang, Chenglong
    Jin, Shangyi
    Li, Jing
    Yang, Yunjiao
    Zeng, Xiaofeng
    Tian, Xinping
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 126 : 77 - 82
  • [8] Treatment of Refractory Takayasu Arteritis with Tocilizumab: 7 Italian Patients from a Single Referral Center
    Tombetti, Enrico
    Franchini, Stefano
    Papa, Maurizio
    Sabbadini, Maria Grazia
    Baldissera, Elena
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (12) : 2047 - 2051
  • [9] Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis
    Kang, Limei
    Liu, Yang
    Luo, Zhongling
    Zhou, Yueyuan
    Chen, Bo
    Yin, Geng
    Xie, Qibing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] One-year clinical and radiological evolution of a patient with refractory Takayasu's arteritis under treatment with tocilizumab
    Bredemeier, M.
    Rocha, C. M.
    Barbosa, M. V.
    Pitrez, E. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) : S98 - S100
12345